Wells Fargo & Company MN Has $761,000 Position in Trupanion, Inc. (NASDAQ:TRUP)

Wells Fargo & Company MN increased its holdings in shares of Trupanion, Inc. (NASDAQ:TRUP) by 44.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 15,798 shares of the financial services provider’s stock after buying an additional 4,836 shares during the period. Wells Fargo & Company MN’s holdings in Trupanion were worth $761,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in TRUP. Baillie Gifford & Co. raised its position in shares of Trupanion by 26.6% during the fourth quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after acquiring an additional 147,341 shares during the last quarter. JPMorgan Chase & Co. increased its position in Trupanion by 458.3% during the 4th quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock valued at $7,620,000 after purchasing an additional 129,782 shares during the period. Trexquant Investment LP raised its holdings in Trupanion by 229.3% during the 4th quarter. Trexquant Investment LP now owns 138,109 shares of the financial services provider’s stock worth $6,657,000 after purchasing an additional 96,174 shares during the last quarter. Hosking Partners LLP lifted its position in shares of Trupanion by 52.5% in the 4th quarter. Hosking Partners LLP now owns 212,720 shares of the financial services provider’s stock worth $10,253,000 after purchasing an additional 73,203 shares during the period. Finally, Barclays PLC boosted its stake in shares of Trupanion by 259.2% in the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after purchasing an additional 47,262 shares during the last quarter.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on the stock. Piper Sandler dropped their target price on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating on the stock in a report on Thursday, February 20th. Stifel Nicolaus dropped their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating on the stock in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $46.60.

Insiders Place Their Bets

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of the business’s stock in a transaction that occurred on Tuesday, March 4th. The stock was sold at an average price of $31.39, for a total transaction of $72,008.66. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at approximately $3,728,629.76. The trade was a 1.89 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Emily Dreyer sold 14,025 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $32.41, for a total value of $454,550.25. Following the completion of the transaction, the senior vice president now owns 27,645 shares in the company, valued at $895,974.45. This represents a 33.66 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 33,792 shares of company stock worth $1,122,802. Insiders own 5.50% of the company’s stock.

Trupanion Stock Performance

Shares of TRUP opened at $36.44 on Friday. Trupanion, Inc. has a one year low of $19.69 and a one year high of $57.90. The company has a market cap of $1.55 billion, a PE ratio of -158.43, a P/E/G ratio of 6.02 and a beta of 1.66. The stock has a 50-day moving average of $35.38 and a 200-day moving average of $44.98. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP) last announced its quarterly earnings data on Thursday, May 1st. The financial services provider reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. During the same period in the previous year, the firm earned ($0.16) earnings per share. The firm’s revenue was up 11.7% on a year-over-year basis. On average, equities research analysts predict that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.